|
Match
|
Document |
Document Title |
|
|
US20110182995 |
MEDICAL AND DENTAL BIOMATERIAL AND METHOD OF USE FOR THE SAME
The embodiments herein provide a dental and medical biomaterial and its use for sealing and/or filling the tooth and bone cavities. In the embodiments herein, the calcium salt, calcium oxide,...
|
|
|
US20120014935 |
RECOMBINANT HUMAN CLN2 PROTEIN AND METHODS OF ITS PRODUCTION AND USE
The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering...
|
|
|
US20110014172 |
Recombinant Human CLN2 Protein and Methods of Its Production and Use
The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering...
|
|
|
US20110250153 |
OLIGOMERIC BIOSURFACTANTS IN DERMATOCOSMETIC COMPOSITIONS
Oligomeric acylated biosurfactants (“OABs”) having low critical micelle concentrations of from about 1.0 ppm to about 200 ppm, preferably less than about 50 ppm, in an aqueous solution of Min...
|
|
|
US20110318405 |
Chemical Combination and Method for Increasing Delivery of Coenzyme Q10
The present invention relates to a chemical combination and method for increasing delivery of Coenzyme Q10. The chemical combination comprises Coenzyme Q10 mixed with at least one chemical. The at...
|
|
|
US20110135620 |
PRODRUG ACTIVATION IN CANCER CELLS USING MOLECULAR SWITCHES
The present invention features a novel protein engineering strategy by combining the domains of two independent proteins into a molecular switch. The invention features polypeptides comprising a...
|
|
|
US20110014247 |
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral...
|
|
|
US20110142800 |
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, methods for treating diabetes mellitus, comprising administering same, and methods for oral...
|
|
|
US20110008308 |
Composition for hair, skin, nails
A pharmaceutical composition for use in hair, skin and nail health maintenance, for combined, sequential or simultaneous administration, in any form, via any biological route. In its optimal...
|
|
|
US20110086014 |
METHOD FOR ENZYMATIC CROSS-LINKING OF A PROTEIN
A method for cross-linking albumin for use as a sealant or glue for a biological system, for example to induce hemostasis and/or prevent leakage of any other fluid from a biological tube or tissue,...
|
|
|
US20110268718 |
CACTUS FRUIT EXTRACT
A method for producing a cactus fruit extract for use in formulating a beverage which can be used in the treatment of veisalgia.
|
|
|
US20120010599 |
INORGANICALLY SURFACE-MODIFIED POLYMERS AND METHODS FOR MAKING AND USING THEM
In alternative embodiments, the invention provides articles of manufacture comprising biocompatible nanostructures comprising PolyEther EtherKetone (PEEK) surface-modified (surface-nanopatterned)...
|
|
|
US20110195058 |
CARDIOVASCULAR SUPPORT SUPPLEMENT AND COMPOSITIONS AND METHODS THEREOF
A cardiovascular support composition is provided comprising red yeast rice, Coenzyme-Q10, and phytosterols. A method for maintaining cardiovascular health is also provided comprising administering...
|
|
|
US20110070218 |
METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM
A method of treating a cancer of the central nervous system in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of an...
|
|
|
US20110212136 |
Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury
A formulation including injectable biodegradable nanospheres and/or microspheres as a delivery system for chondroitinase ABC (cABC) or a functional derivative of cABC to treat acute and chronic...
|
|
|
US20110104246 |
METHOD OF WOUND TREATMENT USING LIQUID GALLIUM NITRATE
A pharmaceutical composition and method for topical wound treatment by topical treatment with gallium salts, preferably gallium nitrate. In a preferred embodiment, the gallium nitrate is in an...
|
|
|
US20100316705 |
SYSTEM FOR EXSANGUINOUS METABOLIC SUPPORT OF AN ORGAN OR TISSUE
An exsanguinous metabolic support system for maintaining an organ or tissue at a near normal metabolic rate is disclosed. The system employs a warm perfusion solution capable of supporting the...
|
|
|
US20110110914 |
METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.
|
|
|
US20120107394 |
IMMUNO-COMPATIBLE HYDROGEL SYSTEM
An immuno-compatible hydrogel system is provided that is resistant to protein binding. The hydrogel system is prepared by contacting a hydrogel solution with a cross-linking agent to form a gel,...
|
|
|
US20110070211 |
Methods of Treating Cancer Using Galanin Retargeted Endopepidases
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
|
|
|
US20110274677 |
Biological Pest Control Mixture Containing D-Limonene and Nutmeg Oil
An organic pest control product comprising nutmeg oil and D-limonene is disclosed. In some embodiments the organic pest control product further comprises a miscibility enhancer to enhance the...
|
|
|
US20120058097 |
COMPOSITIONS INCLUDING A SODIUM CHANNEL BLOCKER AND A B VITAMIN MOLECULE AND METHODS OF USE THEREOF
The invention generally relates to compositions including a sodium channel blocker and a B vitamin molecule and methods of use thereof. In certain embodiments, the invention provides compositions...
|
|
|
US20110123591 |
TUMORICIDAL, BACTERICIDAL, OR VIRICIDAL MACROPHAGE ACTIVATION
The activation of macrophages and methods for treating cancer, bacterial pathogens and viral pathogens are disclosed. In particular, Gc protein is converted to Gc-macrophage activating factor...
|
|
|
US20110311478 |
Combinatorial Methods For Treating Cellular Proliferative Disorders And Immune Deficiencies Using Salicinium
The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become...
|
|
|
US20120063997 |
DELIVERY SYSTEM WITH SCAFFOLDS
An injectable, agent delivery system comprising a composition comprising: (i) an injectable scaffold material comprising discrete particles, which are capable of interacting to form a scaffold; and...
|
|
|
US20110223156 |
REVERSIBLE GEL PROTEIN FORMULATION
Reversible gel protein formulations, including pharmaceutical formulations, that inhibit protein aggregate formation are described, along with containers, e.g., a vial, ampoule or bottle; or an...
|
|
|
US20100303783 |
Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases
The present specification discloses TVEMPs, compositions comprising such toxins and methods of treating urogenital-neurological disorders in a mammal using such TVEMPs and compositions.
|
|
|
US20110274682 |
METHODS FOR PROTEASE ASSISTED PROTEIN DELIVERY
A method for intracellular delivery of single proteins or other cargo molecules by encapsulation within nanocapsules formed by interfacial polymerization of one or more types of monomers and...
|
|
|
US20110217278 |
Medication and Treatment for Disease
A treatment is described for diseases with symptoms that can include fatigue, muscle aches and spasms, weakness, demylenation, and nerve pain. Diseases can include fibromyalgia, depression, and...
|
|
|
US20110027247 |
METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
Methods and formulations for treating oncological disorders in humans using Coenzyme Q10 are described.
|
|
|
US20110082482 |
Materials and Methods for Nerve Repair
The subject invention pertains to compositions and methods for promoting repair of damaged nerve tissue. The compositions and methods of the subject invention can be employed to restore the...
|
|
|
US20110091550 |
Methods for Promoting the Revascularization and Reenervation of CNS Lesions
The present invention provides methods of promoting the revascularization and/or reenervation of central nervous system lesions using an in-situ crosslinkable hydrogel.
|
|
|
US20110236397 |
LIMITED PROTEOLYSIS OF CD2AP AND PROGRESSION OF RENAL DISEASE
Compositions which specifically block cathepsin L function in podocytes, compositions which protect cytoskeletal adaptor protein (CD2AP) for degradation, compositions which modulate expression or...
|
|
|
US20110064747 |
METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
Methods and formulations for treating a sarcoma in humans using an epimetabolic shifter, such as Coenzyme Q10, a building block of CoQ10, a derivative of CoQ10, an analog of CoQ10, a metabolite of...
|
|
|
US20110262418 |
COMPOSITION AND METHODS FOR RELIEF OF NEUROPATHOLOGICAL PAIN
The formulations of the present disclosure alter the perception of pain, especially as experienced by subjects reporting the characteristic features associated with the syndrome known as...
|
|
|
US20110129453 |
Topical skin composition and method for moisturizing the skin
A cosmetic composition with superior moisturizing benefits comprising from approximately 0.3% to approximately 0.9% by weight of bio-chelated mineral blend comprising silicon, magnesium, copper,...
|
|
|
US20110123481 |
ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS
A method of promoting wound healing or connective tissue reconstruction and a method of treating ischemia in a subject in need thereof are disclosed. The methods comprising topically administering...
|
|
|
US20110123488 |
Method of Treatment for Cancers Associated with Elevated HER2 Levels
Novel methods of treating proliferative disorders characterized by elevated Her-2, and the patient is then administered an effective amount of an HSP90 inhibitor.
|
|
|
US20110070186 |
Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
|
|
|
US20110177015 |
SKIN AND HAIR CARE USING EXTRACT FROM CONDITIONED MEDIUM CULTURED BY MESENCHYMAL STEM CELLS AND OTHER REGENERATIVE CELLS
A method and composition for treating dermatological conditions and improving skin condition and helping hair to grow or thicken involves putting mesenchymal stem cells or other cells with...
|
|
|
US20110293589 |
METHOD OF TREATING VITAMIN B12 DEFICIENCY
A novel method and composition for treating vitamin B12 deficiency mammals that fail to respond to oral vitamin B12 therapy.
|
|
|
US20100310532 |
GENE TARGETS IN ANTI-AGING THERAPY AND TISSUE REPAIR
Novel gene and protein targets are described for treatment of cardiac disorders, anti-aging therapies and tissue repair. Identified biomarkers are prognostic of long term survival of patients...
|
|
|
US20110014153 |
REINFORCED TISSUE GRAFT
A biocompatible tissue graft is provided. The tissue graft includes an extracellular matrix patch and a means for reinforcing the patch.
|
|
|
US20110070212 |
Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
|
|
|
US20100303757 |
Methods of Treating Chronic Neurogenic Inflammation Using Interleukin Retargeted Endopepidases
The present specification discloses TVEMPs, compositions comprising such toxins and methods of treating chronic neurogenic inflammation in a mammal using such TVEMPs and compositions.
|
|
|
US20120070422 |
Method of Treating Ocular Disorders
A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically...
|
|
|
US20110008310 |
METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY
The invention features methods, kits, and compositions for mitochondrial replacement in the treatment of disorders arising from mitochondrial dysfunction. The invention also features methods of...
|
|
|
US20110123573 |
Methods and compositions for treating phenylketonuria
Provided herein are methods for treating a subject suffering from phenylketonuria by administering a phenylalanine hydroxylase (“PAH”) and/or a phenylalanine ammonia lyase (“PAL”) to the subject...
|
|
|
US20120027723 |
TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION
The present invention relates to taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration. More particularly the invention...
|
|
|
US20120076771 |
SURFACE MODIFICATION OF SILK FIBROIN MATRICES WITH POLY(ETHYLENE GLYCOL) USEFUL AS ANTI-ADHESION BARRIERS AND ANTI-THROMBOTIC MATERIALS
The present invention provides compositions and methods for the production of silk fibroin matrices surface-PEGylated on one or more surfaces. Such surface-PEGylated silk fibroin matrices can be...
|